The key to sustainable weight loss after GLP-1 treatment The key to sustainable weight loss after GLP-1 treatment The most successful outcomes often happen when patients use GLP-1 medications as a tool not as the only solution
Medicaid and Medicare Savings Programs The federal government has gone back and forth on its coverage of semaglutide for weight loss under Medicaid and Medicare
Bariatric surgery, including gastric bypass, sleeve gastrectomy, and similar procedures, qualifies as an HSA and FSA expense when performed to treat a diagnosed condition such as obesity, type 2 diabetes, or severe cardiovascular disease
In most cases, yes, but moderation is key
Combined, they may produce symptomatic hypoglycemia, particularly in patients who are also taking a sulfonylurea or insulin alongside their GLP-1